Cover Image

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma

Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a ty...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiangye Yin (Author), Yingjie Zhuang (Author), Haiqin Song (Author), Yujian Xu (Author), Fan Zhang (Author), Jianxin Cui (Author), Lei Zhao (Author), Yingjie Yu (Author), Qixu Zhang (Author), Jun Ye (Author), Youbai Chen (Author), Yan Han (Author)
Format:	Book
Published:	Elsevier, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prodrug Approach: NSAID Conjugates of Platinum Compounds as Anti-Cancer Agents
by: NIJA B
Published: (2023)

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
by: Aleen Khoury, et al.
Published: (2022)

METTL3-mediated HPV vaccine enhances the effect of anti PD-1 immunotherapy to alleviate the development of cutaneous squamous cell carcinoma
by: Yingjie Zhang, et al.
Published: (2024)

Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
by: Zhang R, et al.
Published: (2017)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
by: Donata Galbiati, et al.
Published: (2019)

Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells
by: Aleen Khoury, et al.
Published: (2022)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
by: Emma E. Ramsay, et al.
Published: (2014)

Phosphodiester Conjugation of Metronidazole and Dexamethasone as Possible Mutual Prodrug
by: Muthana D. Saud, et al.
Published: (2017)

Phosphodiester Conjugation of Metronidazole and Dexamethasone as Possible Mutual Prodrug
by: Muthana D. Saud, et al.
Published: (2017)

A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
by: Zuojun Li, et al.
Published: (2018)

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
by: Paulina Gonzalez, et al.
Published: (2023)

Nanoalbumin-prodrug conjugates prepared via a thiolation‐and‐conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T‐cell infiltration
by: Long Chen, et al.
Published: (2023)

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
by: Yvonne Lerchbammer-Kreith, et al.
Published: (2023)

Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry
by: Tian Xu, et al.
Published: (2023)

Conjugation of Steroidal and Non â€" Steroidal Anti- Inflammatory Drugs as Possible Mutual Prodrug
by: Muthanna D. Saud
Published: (2017)

Conjugation of Steroidal and Non â€" Steroidal Anti- Inflammatory Drugs as Possible Mutual Prodrug
by: Muthanna D. Saud
Published: (2017)

Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine -Methotrexate Conjugate as Possible Mutual Prodrug
by: Asmaa S. Al-Darraji, et al.
Published: (2019)

The Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine -Methotrexate Conjugate as Possible Mutual Prodrug
by: Asmaa Safwan Al-darraji, et al.
Published: (2019)

Antibody-Drug Conjugate to Treat Meningiomas
by: Kai Chen, et al.
Published: (2021)

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
by: Shih-Jen Chang, et al.
Published: (2022)

Pharmacokinetics of a ternary conjugate based pH-responsive 10-HCPT prodrug nano-micelle delivery system
by: Yang Liu, et al.
Published: (2017)

Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
by: Ahmad Fawzi Hussain, et al.
Published: (2021)

Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024)

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance
by: Yin-Ting Chuang, et al.
Published: (2012)

Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
by: Yonghyun Lee, et al.
Published: (2020)

Targeting cancer with antibody-drug conjugates: Promises and challenges
by: Alexis Q. Dean, et al.
Published: (2021)

Recent advances of antibody drug conjugates for clinical applications
by: Pengxuan Zhao, et al.
Published: (2020)

A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
by: Yixin Sun, et al.
Published: (2019)

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
by: Cui Q, et al.
Published: (2021)

Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021)

Antibody-Drug Conjugates: The Last Decade
by: Nicolas Joubert, et al.
Published: (2020)

A Potential Antibody-Drug Conjugate Targeting Human LIV1 for the Treatment of Triple-Negative Breast Cancer
by: Wei Zhang, et al.
Published: (2023)

Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
by: Amelia C. McCue, et al.
Published: (2024)

An RGD-Conjugated Prodrug Nanoparticle with Blood-Brain-Barrier Penetrability for Neuroprotection Against Cerebral Ischemia-Reperfusion Injury
by: Ayijiang Taledaohan, et al.
Published: (2024)

Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System
by: Giovanna Rassu, et al.
Published: (2023)

Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy
by: Fan Shi, et al.
Published: (2022)

Antibody-drug conjugates: Recent advances in payloads
by: Zhijia Wang, et al.
Published: (2023)

Exploration of the antibody-drug conjugate clinical landscape
by: Heather Maecker, et al.
Published: (2023)

Therapeutic index improvement of antibody-drug conjugates
by: Hans-Peter Gerber, et al.
Published: (2023)